Hologic's Aptima® Zika Virus Assay Gains CE Marking
The Aptima® Zika Virus diagnostic assay from Hologic is now CE marked in Europe for the detection and diagnosis of the Zika virus in patients at risk of exposure to Zika or with signs and symptoms of the virus. The Aptima® Zika Virus assay is a molecular diagnostic test that identifies the presence of Zika RNA in human serum, plasma and urine specimens, that can be used up to 14 days following the onset of symptoms.
The Aptima® Zika Virus assay is the latest Hologic test designed to run on the Company’s Panther® system, a market-leading, integrated platform that fully automates all aspects of nucleic acid amplification testing. By reducing hands-on time, the Panther® system helps to minimize labor needs and the potential for manual errors.
To learn more about the Aptima® Zika Virus assay, please visit www.hologic.com/zika.
Tags: Zika Virus
Date Published: February 21, 2017
Source article link: Hologic Inc. » company contact details